{"id":50551,"date":"2025-10-01T10:37:47","date_gmt":"2025-10-01T05:07:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=50551"},"modified":"2025-10-01T10:38:40","modified_gmt":"2025-10-01T05:08:40","slug":"aptus-pharma-ipo-listing","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-listing\/","title":{"rendered":"Aptus Pharma IPO Listing at 15.42% Premium at \u20b980.80 Per Share"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Latest Updates on Aptus Pharma Limited<\/em><\/strong><\/a><\/p><p><strong><em>Aptus Pharma IPO Listing:<\/em><\/strong> The Aptus Pharma IPO was subscribed 22.27 times as of its closing. In this subscription, qualified institutional buyers (QIBs) received 1.24 times the allocation, and non-institutional investors (NIIs) received 28.75 times the allocation. The retail quota of the issue was subscribed to 33.33%. Before delving deeper into the topic, go through the details of the Aptus Pharma IPO.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-listing\/#Aptus_Pharma_IPO_Listing\" title=\"Aptus Pharma IPO Listing\">Aptus Pharma IPO Listing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-listing\/#Aptus_Pharma_IPO_Details\" title=\"Aptus Pharma IPO Details\">Aptus Pharma IPO Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-listing\/#About_Aptus_Pharma_Limited\" title=\"About Aptus Pharma Limited\">About Aptus Pharma Limited<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-listing\/#Aptus_Pharma_Limited_Financials\" title=\"Aptus Pharma Limited Financials\">Aptus Pharma Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-listing\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-listing\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Listing\"><\/span><strong>Aptus Pharma IPO Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the BSE (National Stock Exchange), shares are listed at \u20b980.80 per share, representing a 15.42% premium over the issue price of \u20b970 per share.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Details\"><\/span><strong>Aptus Pharma IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>It is a bookbuilding IPO of \u20b913.02 crore, comprising a fresh issue of 0.19 crore shares. The problem will be listed on BSE and SME on its tentative listing date, 30th September 2025.<\/p><p>The <strong>Aptus Pharma IPO<\/strong> date is fixed between 23rd September 2025 and 25th September 2025. The face value of Aptus Pharma IPO shares stands at \u20b910 per share, and the IPO price is set at \u20b965.00 to \u20b970.00 per share.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>23rd September 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>25th September 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>26th September 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>29th September 2025<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>18,60,000 shares(aggregating up to \u20b913.02 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>2,000 shares<\/td><\/tr><tr><td><strong>Issue Price Band<\/strong><\/td><td>\u20b965.00 to \u20b970.00 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>30th September 2025<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Aptus_Pharma_Limited\"><\/span><strong>About Aptus Pharma Limited<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids &amp; PPIs, pain management, anti-inflammatories, antibiotics, cardiology &amp; antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_Limited_Financials\"><\/span><strong>Aptus Pharma Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is crucial before applying for the <strong>Aptus Pharma IPO.<\/strong> Refer to the table to learn about Aptus Pharma Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>21.92<\/td><td>10.03<\/td><td>6.22<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>24.64<\/td><td>17.88<\/td><td>13.90<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>3.10<\/td><td>0.80<\/td><td>0.19<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>4.76<\/td><td>1.49<\/td><td>0.57<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>6.97<\/td><td>1.77<\/td><td>0.97<\/td><\/tr><tr><td><strong>Reserve and surplus<\/strong><\/td><td>1.97<\/td><td>1.47<\/td><td>0.67<\/td><\/tr><tr><td><strong>Total Borrowing<\/strong><\/td><td>10.36<\/td><td>5.31<\/td><td>2.21<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Aptus Pharma&nbsp; Limited&#8217;s revenue increased by 38% from \u20b917.88 crores in March 2024 to \u20b924.64 crores in March 2025. Moreover, the company&#8217;s PAT rose by 288% from \u20b90.80 crores to \u20b93.10 crores.<\/p><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/top-10-penny-stocks-in-india\">Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/best-stocks-to-buy-today-6\">Best Stocks to Buy Today: Explore Best Stocks With Expected Trends<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/milky-mist-dairy-foods-ipo-details\">Milky Mist Dairy Foods IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/karbonsteel-engineering-ipo-gmp-review\">Karbonsteel Engineering IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/taurian-mps-ipo-gmp-review\">Taurian MPS IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/shringar-house-of-mangalsutra-ipo-gmp-review\">Shringar House of Mangalsutra IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/dev-accelerator-ipo-gmp-review\">Dev Accelerator IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/vigor-plast-india-ipo-listing-preview\">Vigor Plast India IPO Listing Preview: What to Expect Now?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/krupalu-metals-ipo-gmp-live-updates-2\">Krupalu Metals IPO GMP: Day 3 IPO Live Updates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Latest Updates on Aptus Pharma Limited Aptus Pharma IPO Listing: The Aptus Pharma IPO was subscribed 22.27 times as of its closing. In this subscription, qualified institutional buyers (QIBs) received 1.24 times the allocation, and non-institutional investors (NIIs) received 28.75 times the allocation. The retail quota of the issue<\/p>\n","protected":false},"author":23,"featured_media":50552,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[2304],"class_list":["post-50551","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-aptus-pharma-ipo"],"metadata":{"_edit_lock":["1759295320:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_seo_score":["79"],"rank_math_primary_category":["1281"],"rank_math_title":["Aptus Pharma IPO Listing: Check Experts' Verdicts Here"],"rank_math_description":["Aptus Pharma IPO Listing at \u20b980.80, a Premium of 4.% over the IPO price of \u20b9414 per share. What should be your next move on the Aptus Pharma IPO? Read more.\r\n"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_focus_keyword":["Aptus Pharma IPO"],"_thumbnail_id":["50552"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["3607"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/aptus-pharma-ipo-listing"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/10\/01103023\/Aptus-Pharma-IPO-Listing-Today.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/50551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=50551"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/50551\/revisions"}],"predecessor-version":[{"id":50553,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/50551\/revisions\/50553"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/50552"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=50551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=50551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=50551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}